close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Aditxt, Inc. - Common Stock (NQ:ADTX)

0.5587 -0.0274 (-4.67%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 19, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Aditxt, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Organ Donation, Transplantation: Challenges and How We Can Help More Individuals
Via Investor Brand Network
BioMedNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Closes on $1.9M Registered Direct Offering
Via Investor Brand Network
News headline image
Aditxt Announces Closing of $1.9 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
From Aditxt,® Inc.
Via Business Wire
BioMedNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Registered Direct Offering Expected to Total $1.9M
Via Investor Brand Network
InvestorNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Registered Direct Offering Expected to Total $1.9M
Via Investor Brand Network
News headline image
Aditxt Announces $1.9 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
From Aditxt, Inc.
Via Business Wire
BioMedNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Inks Asset Purchase Agreement for 50% Ownership of Global Response Aid
Via Investor Brand Network
News headline image
Aditxt Signs Asset Purchase Agreement to Acquire Fifty Percent Ownership of Global Response Aid – with Rights to Manufacture and Market Broad-Spectrum Antiviral Drug Avigan
From Aditxt, Inc.
Via Business Wire
Allergic Reactions Caused by Gel Nail Polishes on the Rise
Via Investor Brand Network
BioMedNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Releases Shareholder Update on Major Programs, M&A Plans
Via Investor Brand Network
News headline image
Aditxt Issues Shareholder Update
From Aditxt, Inc.
Via Business Wire
US Federal Agency Plans to Overhaul Organ Transplant Network
Via Investor Brand Network
Study Describes Link Between Viral infections, Autoimmune Diseases
Via Investor Brand Network
Study Suggests Giving Babies Peanut Butter Cuts Allergy Risk
Via Investor Brand Network
Debate Rages Regarding Patients Listing on Multiple Organ Transplant Wait Lists
Via Investor Brand Network
Researchers ID Substance That Could Make Autoimmune Disease Treatment Possible
Via Investor Brand Network
How Research on Blood Cancer Could Benefit the Organ Transplant Field
Via Investor Brand Network
FDA Issues Warning about Reliability of Food Allergy Skin Tests
Via Investor Brand Network
TinyGemsBreaks – Aditxt Inc. (NASDAQ: ADTX) Appoints Veteran of Media Industry as Chief Content, Engagement Officer
Via Investor Brand Network
News headline image
Aditxt Names Media Industry Veteran Maureen Connolly as Chief Content and Engagement Officer
From Aditxt, Inc.
Via Business Wire
BioMedNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Retains Top Banking Firm to Support Growth, Revenue-Generating Strategy
Via Investor Brand Network
News headline image
Aditxt Retains Riverside Management Group as Advisor to Support Strategic M&A Driven Acquisitions by Subsidiary Pearsanta, Inc.
From Aditxt, Inc.
Via Business Wire
Study Finds Organ Transplant Recipients Undervaccinated
Via Investor Brand Network
Consuming Too Much Salt May Trigger Autoimmune Illnesses
Via Investor Brand Network
TinyGemsBreaks – Aditxt Inc. (NASDAQ: ADTX) Forms US-Based Subsidiary with Focus to Expand Innovation Platforms
Via Investor Brand Network
News headline image
Aditxt Forms its Second Subsidiary, Pearsanta, Inc., to Accelerate the Growth of its AditxtScore™ Program and Appoints Healthcare Executive and Current Head of AditxtScore™ Anthony Voorhies to Serve as its President
From Aditxt, Inc.
Via Business Wire
Food Allergies Worsen Cost of Living for Impacted Individuals
Via Investor Brand Network
Topics Economy
BioMedNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Reaches Pivotal Milestone to Advance ADI (TM) Technology
Via Investor Brand Network
BioMedNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Dedicated to New Era of Precision Medicine
Via Investor Brand Network
Aditxt, Inc. (NASDAQ: ADTX) Bolsters Goal to Conduct First-In-Human Clinical Trial Evaluating ADI(TM) Tech with Formation of Adimune, Inc. Subsidiary; Appoints Industry Veteran as Subsidiary Chairman and CEO
Via Investor Brand Network
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today